Efficacy and adverse events of five targeted agents in the treatment of advanced or metastatic non-small-cell lung cancer: A network meta-analysis of nine eligible randomized controlled trials involving 5,059 patients

Meta Analysis ◽

Small Cell ◽

Controlled Trials ◽

Targeted Agents ◽

Small Cell Lung ◽

Risk of adverse events with bevacizumab addition to therapy in advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials

OncoTargets and Therapy ◽

10.2147/ott.s96156 ◽

2016 ◽

pp. 2421 ◽

Cited By ~ 1

Author(s):

Han Yang ◽

Xi-Xi Lai ◽

Ren-Ai Xu ◽

Yu-Ping Li

Keyword(s):

Lung Cancer ◽

Adverse Events ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Controlled Trials ◽

Small Cell Lung ◽

Role of pemetrexed in advanced non-small-cell lung cancer: meta-analysis of randomized controlled trials, with histology subgroup analysis

Current Oncology ◽

10.3747//co.19.891 ◽

2012 ◽

Vol 19 (1) ◽

Author(s):

K. Alsaleh ◽

C. Quinton ◽

P. M. Ellis

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Subgroup Analysis ◽

Meta Analysis ◽

Small Cell ◽

Controlled Trials ◽

Small Cell Lung ◽

The benefits and risks of CTLA4 inhibitor plus PD1/PDL1 inhibitor in stage IIIB/IV non‐small cell lung cancer: A systematic analysis and meta‐analysis based on randomized controlled trials

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13465 ◽

2021 ◽

Author(s):

Qiangyun Liu ◽

Zige Fang ◽

Miaowen Liu ◽

Ruoxin Xu ◽

Fengming Yi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Controlled Trials ◽

Small Cell Lung ◽

Systematic Analysis ◽

Effectiveness of neoadjuvant chemotherapy on the survival outcomes of patients with resectable non-small-cell lung cancer: A meta-analysis of randomized controlled trials

Surgical Oncology ◽

10.1016/j.suronc.2021.101590 ◽

2021 ◽

pp. 101590

Author(s):

Yunfeng Zhang ◽

Xiayun Hu ◽

Dapeng Liu ◽

Rui Wang ◽

Xin Sun ◽

...

Keyword(s):

Lung Cancer ◽

Neoadjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Survival Outcomes ◽

Controlled Trials ◽

Small Cell Lung ◽

Risk profile of bevacizumab in patients with non-small cell lung cancer: A meta-analysis of randomized controlled trials

Acta Oncologica ◽

10.3109/0284186x.2011.631579 ◽

2011 ◽

Vol 51 (2) ◽

pp. 151-156 ◽

Cited By ~ 9

Author(s):

Chao Cao ◽

Jianmiao Wang ◽

Hansvin Bunjhoo ◽

Yongjian Xu ◽

Huijuan Fang

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Risk Profile ◽

Small Cell ◽

Controlled Trials ◽

Small Cell Lung ◽

Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: a meta-analysis of Phase III randomized controlled trials

OncoTargets and Therapy ◽

10.2147/ott.s85648 ◽

2015 ◽

pp. 2023 ◽

Cited By ~ 18

Author(s):

Xuan He ◽

Yuanming Li ◽

Ji Wang

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Phase Iii ◽

Controlled Trials ◽

Efficacy And Safety ◽

Small Cell Lung ◽

A Meta-Analysis of the Efficacy and Toxicity of Twice-Daily vs. Once-Daily Concurrent Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer Based on Randomized Controlled Trials

Frontiers in Oncology ◽

10.3389/fonc.2019.01460 ◽

2020 ◽

Vol 9 ◽

Author(s):

Qian Wu ◽

Yiting Xiong ◽

Shujuan Zhang ◽

Xinling Chen ◽

Fengming Yi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Concurrent Chemoradiotherapy ◽

Meta Analysis ◽

Small Cell ◽

Controlled Trials ◽

Small Cell Lung ◽

Once Daily ◽

Efficacy and safety of pembrolizumab for treating advanced non-small-cell lung cancer: a meta-analysis of phase II and III randomized controlled trials

Journal of Chemotherapy ◽

10.1080/1120009x.2021.2014714 ◽

2021 ◽

pp. 1-9

Author(s):

Tianyao Gong ◽

Lei Liu ◽

Yufei Liu ◽

Ke Liu ◽

Yang Yang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Controlled Trials ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Randomized Controlled ◽

Phase Ii And Iii

The Impact of Afatinib on Survival in Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials

Journal of Cancer ◽

10.7150/jca.27528 ◽

2019 ◽

Vol 10 (4) ◽

pp. 885-892

Author(s):

Chi Wang ◽

Yun Li ◽

Li Ke ◽

Lejie Cao ◽

Pingsheng Fan ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled ◽

The Impact

Clinical efficacy and safety of sodium cantharidinate plus chemotherapy in non-small-cell lung cancer: A systematic review and meta-analysis of 38 randomized controlled trials

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.12761 ◽

2018 ◽

Vol 44 (1) ◽

pp. 23-38 ◽

Cited By ~ 1

Author(s):

Zheng Xiao ◽

Chengqiong Wang ◽

Zhouke Tan ◽

Shanshan Hu ◽

Yali Chen ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Controlled Trials ◽

Efficacy And Safety ◽

Small Cell Lung ◽